Cr3022 | List of Frontiers open access articles

Data Report

Published on 14 Dec 2020

A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex—An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface

in Experimental Pharmacology and Drug Discovery

Charlie Nichols
Joseph Ng
Annika Keshu
Franca Fraternali
Gian F. De Nicola

Frontiers in Pharmacology

doi 10.3389/fphar.2020.615211

5,993 views
9 citations

Original Research

Published on 10 Jun 2022

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants

in Vaccines and Molecular Therapeutics

Ariel Isaacs
Alberto A. Amarilla
Julio Aguado
Naphak Modhiran
Eduardo A. Albornoz
Alireza A. Baradar
Christopher L. D. McMillan
Jovin J. Y. Choo
Adi Idris
Aroon Supramaniam

Frontiers in Immunology

doi 10.3389/fimmu.2022.926262

5,105 views
20 citations

Original Research

Published on 24 Dec 2021

Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques

in Viral Immunology

Patrick J. Madden
Muhammad S. Arif
Mark E. Becker
Michael D. McRaven
Ann M. Carias
Ramon Lorenzo-Redondo
Sixia Xiao
Cecily C. Midkiff
Robert V. Blair
Elizabeth Lake Potter

Frontiers in Immunology

doi 10.3389/fimmu.2021.810047

6,185 views
6 citations

Original Research

Published on 03 May 2023

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

in Microbial Vaccines

Kaikai Yu
Bin Liu
Haotian Yu
Chengbiao Sun
Xuefeng Wang
Guorui Li
Mingxin Dong
Yan Wang
Jianxu Zhang
Na Xu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1155293

4,001 views
6 citations

Original Research

Published on 16 Sep 2024

Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium

in Vaccines and Molecular Therapeutics

Kohei Togami
Whitney Wolf
Lucas C. Olson
Madison Card
Limei Shen
Alison Schaefer
Kenichi Okuda
Larry Zeitlin
Michael Pauly
Kevin Whaley

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371156

4,767 views
3 citations

Original Research

Published on 01 Feb 2022

In Planta Production of the Receptor-Binding Domain From SARS-CoV-2 With Human Blood Group A Glycan Structures

in Chemical Biology

Julia König-Beihammer
Ulrike Vavra
Yun-Ji Shin
Christiane Veit
Clemens Grünwald-Gruber
Yasmin Gillitschka
Jasmin Huber
Manuela Hofner
Klemens Vierlinger
Dieter Mitteregger

Frontiers in Chemistry

doi 10.3389/fchem.2021.816544

3,887 views
13 citations

Correction

Published on 24 Aug 2023

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

in Microbial Vaccines

Kaikai Yu
Bin Liu
Haotian Yu
Chengbiao Sun
Xuefeng Wang
Guorui Li
Mingxin Dong
Yan Wang
Jianxu Zhang
Na Xu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1264974

1,614 views
1 citation

Articles

A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex—An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants

Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium

In Planta Production of the Receptor-Binding Domain From SARS-CoV-2 With Human Blood Group A Glycan Structures

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022